These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13985901)

  • 21. Vaccination of adults with a British oral poliomyelitis vaccine prepared from Sabin strains.
    GOFFE A; POLLOCK TM; SHAND FL
    Br Med J; 1961 Jul; 2(5247):272-5. PubMed ID: 13706303
    [No Abstract]   [Full Text] [Related]  

  • 22. [ON SO-CALLED CASES OF POLIOMYELITIS AFTER VACCINATION WITH TYPE III LIVE SABIN VACCINE IN THE USA].
    SKOVRANEK V
    Cesk Epidemiol Mikrobiol Imunol; 1963 May; 12():190-2. PubMed ID: 14072717
    [No Abstract]   [Full Text] [Related]  

  • 23. POLIO VACCINE LIVE ORAL (SABIN) (ADMINISTRATION IN BOMBAY TO SMALL GROUPS).
    MEHERHOMJI KM; RAO VK; DAVE KH; GHARPURE PV; JHALA HI
    Indian J Pathol Bacteriol; 1964 Apr; 55():74-85. PubMed ID: 14157679
    [No Abstract]   [Full Text] [Related]  

  • 24. ORAL POLIO VACCINATION PROGRAM IN HILLSBOROUGH COUNTY USING A SABIN TRIVALENT VACCINE.
    NEILL JS; BURKE SK; BOND JO; SCHNEIDER NJ
    South Med J; 1963 Nov; 56():1239-44. PubMed ID: 14078371
    [No Abstract]   [Full Text] [Related]  

  • 25. Poliovirus type 1 isolated from a vaccine-associated case of paralytic poliomyelitis in Brazil.
    Friedrich F; Filippis AM; Ferreira FC; Oliveira MJ; Schatzmayr HG; Da-Silva EE
    Braz J Med Biol Res; 1996 Jan; 29(1):15-8. PubMed ID: 8731326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Circulation of cytopathogenic enteric viruses in Lombardy 7 years after the introduction of vaccination against poliomyelitis with the Sabin vaccine].
    Galli MG
    Ann Sclavo; 1974; 16(6):569-76. PubMed ID: 4460896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Isolation of poliovirus in poliomyelitic patients vaccinated with Sabin vaccine].
    Andreoni G; Curatolo D; Cervini E; Provvidenza G; Rocchi G; Velli V
    G Mal Infett Parassit; 1966 Oct; 18(10):662-3. PubMed ID: 4297675
    [No Abstract]   [Full Text] [Related]  

  • 28. [Poliomyelitis vaccination, Sabin type, in 1-month-old and 3-month-old infants].
    Neves WE; Rodrigues MC; Kipnis J; Carvalho RP; Amato Neto V
    Rev Inst Med Trop Sao Paulo; 1968; 10(6):376-82. PubMed ID: 4303642
    [No Abstract]   [Full Text] [Related]  

  • 29. [Circulation of cytopathogenic enteric viruses in Lombardy 11 years after introduction of anti-poliomyelitis vaccination with the Sabin vaccine].
    Galli MG
    Ann Sclavo; 1977; 19(6):1157-62. PubMed ID: 218504
    [No Abstract]   [Full Text] [Related]  

  • 30. [Type I poliomyelitis epidemic in France and use of homotypic vaccine (Sabin LSc 2ab). 3. Study of the non-poliomyelitic enteric virus isolated before and after vaccination. Predominance of Coxsackie A7 virus].
    Netter R; Drouhet V; Grist NR; Delpy J
    Arch Gesamte Virusforsch; 1966; 18(1):72-9. PubMed ID: 4294188
    [No Abstract]   [Full Text] [Related]  

  • 31. [Complications of polio vaccination with Sabin vaccine].
    Ammundsen E
    Fra Sundhedsstyr; 1968 Mar; 4(25):337-8. PubMed ID: 5758675
    [No Abstract]   [Full Text] [Related]  

  • 32. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
    Friedrich F
    Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of strains of type 3 poliovirus by oligonucleotide mapping.
    Minor PD
    J Gen Virol; 1982 Apr; 59(Pt 2):307-17. PubMed ID: 6281371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prospects in the field of the antipolio vaccination (author's transl)].
    Focà A
    Ann Sclavo; 1980; 22(1):22-6. PubMed ID: 7018412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.
    Friedrich F; Da-Silva EF; Schatzmayr HG
    Acta Virol; 1996 Feb; 40(1):27-33. PubMed ID: 8886095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Complement fixation test after vaccination with live poliomyelitis vaccine (Sabin strains)].
    Terraillon J; Sohier R; Brigaud M; Gramusset J; Laconche N; Blondeau G; Feroldi C
    Ann Inst Pasteur (Paris); 1967 Jan; 112(1):54-64. PubMed ID: 6031425
    [No Abstract]   [Full Text] [Related]  

  • 38. [CONSIDERATIONS ON REACTIVE MANIFESTATIONS AFTER SABIN ANTI-POLIO VACCINATION].
    MORRONE G
    Pediatria (Napoli); 1964 Dec; 72():1363-9. PubMed ID: 14255392
    [No Abstract]   [Full Text] [Related]  

  • 39. Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy.
    Băicuş A; Persu A; Popescu M; Penciu A; Stavri S; Soare A; Grecu N; Szmal C; Oprişan G
    Roum Arch Microbiol Immunol; 2009; 68(3):145-50. PubMed ID: 20361534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.